Healthcare providers must offer palliative treatment to parents of neonates with hypoplastic left heart syndrome

Archives of Pediatrics and Adolescent Medicine

Volumn 162, Issue 9, 2008, Pages 844-848

  Kon, Alexander A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTOPULMONARY SHUNT; CHILD CARE; DECISION MAKING; HEALTH CARE PERSONNEL; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFORMED CONSENT; NOTE; PALLIATIVE THERAPY; PRIORITY JOURNAL; SURVIVAL; TRICUSPID VALVE ATRESIA;

DECISION MAKING; HEALTH PERSONNEL; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT, NEWBORN; PALLIATIVE CARE; PARENTS;

EID: 50949098293     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2008.3     Document Type: Note

References (39)

1. Chang RK, Chen AY, Klitzner TS. Clinical management of infants with hypoplastic left heart syndrome in the United States, 1988-1997. Pediatrics. 2002;110(2, pt 1):292-298.
2. Kon AA. Current outcomes and considerations in hypoplastic left heart syndrome. Curr Pediatr Rev. 2005;1(3):243-248.
3. Norwood WI, Kirklin JK, Sanders SP. Hypoplastic left heart syndrome: experience with palliative surgery. Am J Cardiol. 1980;45(1):87-91.
4. Bailey LL, Nehlsen-Cannarella SL, Doroshow RW, et al. Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med. 1986;315(15):949-951.
5. Pizarro C, Norwood WI. Pulmonary artery banding before Norwood procedure. Ann Thorac Surg. 2003;75(3):1008-1010.
6. Tworetzky W, Wilkins-Haug L, Jennings RW, et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation. 2004;110(15):2125-2131.
7. Alsoufi B, Bennetts J, Verma S, Caldarone CA. New developments in the treatment of hypoplastic left heart syndrome. Pediatrics. 2007;119(1):109-117.
8. Kon AA, Ackerson L, Lo B. How pediatricians counsel parents when no "best-choice" treatment exists: lessons to be learned from the hypoplastic left heart syndrome. Arch Pediatr Adolesc Med. 2004;158(5):436-441.
9. Kon AA, Wernovsky G. Should non-surgical care be offered to parents of neonates with hypoplastic left heart syndrome? [pro-con debate]. Presented at: 9th Annual Update on Pediatric Cardiovascular Disease; Scottsdale, AZ; February 10, 2006.
10. Beauchamp T, Childress J. Principles of Biomedical Ethics. 5th ed. New York, NY: Oxford University Press; 2001.
11. Lo B. Resolving Ethical Dilemmas: A Guide for Clinicians. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2000.
12. Informed consent, parental permission, and assent in pediatric practice: Committee on Bioethics, American Academy of Pediatrics. Pediatrics. 1995;95(2):314-317.
13. American Medical Association. Informed consent and decision-making in health care [American Medical Association policy No. H-140.989]. http://www.ama-assn.org/apps/pf_new/pf_online?f_n=resultLink&doc= policyfiles/HnE/H-140.989.HTM&s_t=H-140.989&catg=AMA/HnE&catg=AMA/ BnGnC&catg=AMA/DIR&&nth=1&&st_p=0&nth=1&. Accessed March 15, 2007.
14. American College of Surgeons. Statements on principles: relation of the surgeon to the patient, informed consent (section II, part A). http://www.facs.org/fellows_info/statements/stonprin.html#anchor171960. Revised September 21, 2006; Accessed March 15, 2007.
15. Tabbutt S, Dominguez TE, Ravishankar C, et al. Outcomes after the stage I reconstruction comparing the right ventricular to pulmonary artery conduit with the modified Blalock Taussig shunt. Ann Thorac Surg. 2005;80(5):1582-1591.
16. Ballweg JA, Dominguez TE, Ravishankar C, et al. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at stage 2 reconstruction. J Thorac Cardiovasc Surg. 2007;134(2):297-303.
17. Gentles TL, Mayer JE Jr, Gauvreau K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114(3):376-391.
18. Chrisant MR, Naftel DC, Drummond-Webb J, et al. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant. 2005;24(5):576-582.
19. Warshofsky MK, Dominguez M, Eisenberg MS, et al. Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies are independently associated with decreased graft survival in cardiac transplant recipients. Am J Cardiol. 2001;88(1):30-34.
20. Morales DL, Dreyer WJ, Denfield SW, et al. Over two decades of pediatric heart transplantation: how has survival changed [published online ahead of print January 29, 2007]? J Thorac Cardiovasc Surg. 2007;133(3):632-639.
21. Shillingford AJ, Ittenbach RF, Marino BS, et al. Aortic morphometry and microcephaly in hypoplastic left heart syndrome. Cardiol Young. 2007;17(2):189-195.
22. Mahle WT, Visconti KJ, Freier MC, et al. Relationship of surgical approach to neurodevelopmental outcomes in hypoplastic left heart syndrome. Pediatrics. 2006;117(1):e90-e97.
23. Mahle WT, Clancy RR, Moss EM, Gerdes M, Jobes DR, Wernovsky G. Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome. Pediatrics. 2000;105(5):1082-1089.
24. Mitchell ME, Ittenbach RF, Gaynor JW, Wernovsky G, Nicolson S, Spray TL. Intermediate outcomes after the Fontan procedure in the current era. J Thorac Cardiovasc Surg. 2006;131(1):172-180.
25. Givertz MM, Hartley LH, Colucci WS. Long-term sequential changes in exercise capacity and chronotropic responsiveness after cardiac transplantation. Circulation. 1997;96(1):232-237.
26. Quigg R, Salyer J, Mohanty PK, Simpson P. Impaired exercise capacity late after cardiac transplantation: influence of chronotropic incompetence, hypertension, and calcium channel blockers. Am Heart J. 1998;136(3):465-473.
27. Corrow C, Lapuk S, Mazzarella K, Sable A, Leopold H, Eisenfeld L. Hypoplastic left heart syndrome: factors influencing therapeutic choice. Conn Med. 2001;65(4):195-203.
28. Osiovich H, Phillipos E, Byrne P, Robertson M. Hypoplastic left heart syndrome: "to treat or not to treat". J Perinatol. 2000;20(6):363-365.
29. Vandvik IH, Forde R. Ethical issues in parental decision-making: an interview study of mothers of children with hypoplastic left heart syndrome. Acta Paediatr. 2000;89(9):1129-1133.
30. Munn MB, Brumfield CG, Lau Y, Colvin EV. Prenatally diagnosed hypoplastic left heart syndrome: outcomes after postnatal surgery. J Matern Fetal Med. 1999;8(4):147-150.
31. Kon AA, Ackerson L, Lo B. Choices physicians would make if they were the parents of a child with hypoplastic left heart syndrome. Am J Cardiol. 2003;91(12):1506-1509.
32. Garson A, Bricker JT, McNamara DG. The Science and Practice of Pediatric Cardiology. Philadelphia, PA: Lea & Febiger; 1990.
33. Catlin A, Carter B. Creation of a neonatal end-of-life palliative care protocol. J Perinatol. 2002; 22(3):184-195.
34. Kuebelbeck A. Waiting With Gabriel: A Story of Cherishing a Baby's Brief Life. Chicago, IL: Loyola Press; 2003.
35. Curlin FA, Lawrence RE, Chin MH, Lantos JD. Religion, conscience, and controversial clinical practices. N Engl J Med. 2007;356(6):593-600.
36. Loewy EH. Ethical considerations in executing and implementing advance directives. Arch Intern Med. 1998;158(4):321-324.
37. Carlet J, Thijs LG, Antonelli M, et al. Challenges in end-of-life care in the ICU: Statement of the 5th International Consensus Conference in Critical Care, Brussels, Belgium, April 2003. Intensive Care Med. 2004;30(5):770-784.
38. Thompson BT, Cox PN, Antonelli M, et al. Challenges in end-of-life care in the ICU: Statement of the 5th International Consensus Conference in Critical Care, Brussels, Belgium, April 2003: executive summary. Crit Care Med. 2004;32(8):1781-1784.
39. Kon AA. Answering the question: "doctor, if this were your child, what would you do?" Pediatrics. 2006;118(1):393-397.